MAGNESIUM OXIDE- magnesium oxide tablet 
GRAXCELL PHARMACEUTICAL, LLC

----------

GRAXCELL pHARMACEUTICAL MAGNESIUM OXIDE 400 MG

SUPPLEMENT FACTS

Supplement Facts

USES

DRUG INTERACTION PRECAUTIONS:

This product may interact with certain prescription drugs If you are presently taking a prescription drug, do not take this product without

consulting your doctor or other health professional

WARNINGS

Not recommended for use in ammounts over the recommended daily intake of 400 mg per day (1 tablet). Ask a doctor or pharmacist

before use if you have a known allergy to this product. Stop use and contact a doctor if allergic reaction occurs. Consult a doctor before using this product if you have kidney disease or are pregnant or nursing a baby. May have a laxative effect.

DIRECTIONS

Adults: Take one tablet daily with a meal as a dietary supplement or as directed by a doctor

OTHER INGREDIENTS

Microcrystalline Cellulose, Corn Starch, Magnesium Stearate

OTHER INFORMATION

Label

MAGNESIUM OXIDE 
magnesium oxide tablet
Product Information
Product TypeDIETARY SUPPLEMENTItem Code (Source)NHRIC:70795-1151
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Magnesium Oxide (UNII: 3A3U0GI71G) (Magnesium Cation - UNII:T6V3LHY838) Magnesium Oxide400 mg
Inactive Ingredients
Ingredient NameStrength
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
STARCH, CORN (UNII: O8232NY3SJ)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NHRIC:70795-1151-2120 in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
DIETARY SUPPLEMENT10/02/2017
Supplement Facts
Serving Size : Serving per Container :
Amount Per Serving% Daily Value
color
scoring1
shape
size (solid drugs)11 mm
imprint
Labeler - GRAXCELL PHARMACEUTICAL, LLC (056556923)

Revised: 11/2020
Document Id: bfc1437d-5909-49a7-ae63-5d859f6786a4
Set id: 3e5d877a-6265-41ff-8b0c-ca07fe34180d
Version: 2
Effective Time: 20201116
 
GRAXCELL PHARMACEUTICAL, LLC